MTOR and cancer: Specifically, PTPN6 and PTPN11 are involved in the phosphoinositide 3 kinase/AKT/mammalian target of rapamycin (PI3K/AKT/mTOR) signaling pathway [40], which has been implicated in cancer progression and metastasis [41].